Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent - PubMed (original) (raw)
Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent
A Hiragun et al. J Cell Physiol. 1988 Jan.
Abstract
A highly active adipogenic agent was identified in an in vitro adipose conversion system. This agent, ADD 4743 (or ADD), was synthesized by Takeda Chemical Industries (Osaka) as a 3-hydroxy derivative of an oral antidiabetic agent, ciglitazone, and has been presumed to be an active metabolite of the latter substance. When ST 13 mouse preadipose cells were treated with micromolar concentrations of ADD they rapidly and uniformly converted into lipid-accumulating adipocytelike cells within 8-11 days after cell seeding. The degree of adipose conversion and lipid accumulation induced by ADD far exceeded those of the previously known inducing agents such as indomethacin plus insulin. The highly potent adipogenic activity of ADD was confirmed with two other preadipose cell lines (3T3 L1 and RMT rat preadipose cells). In addition to adipogenic activity, ADD inhibited cell proliferation of preadipose cells specifically. Activity of ADD induced lipid accumulation and growth inhibition of ST 13 cells, exhibiting very similar dose-response relationships. Cell proliferation or triacylglycerol content of nonadipocytic mesenchymal cells or epithelial cells were not affected by ADD. These observations strongly suggest that ADD-induced growth inhibition is not due to the nonspecific toxicity of the drug but is tightly associated with the adipocytic character of the treated cells. The present observation provides evidence that ADD would be a powerful agent in studies that involve preadipocyte differentiation.
Similar articles
- Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells.
Sparks RL, Strauss EE, Zygmunt AI, Phelan TE. Sparks RL, et al. J Cell Physiol. 1991 Jan;146(1):101-9. doi: 10.1002/jcp.1041460114. J Cell Physiol. 1991. PMID: 1990013 - Establishment of a human preadipose cell line, HPB-AML-I: refractory to PPARgamma-mediated adipogenic stimulation.
Torii I, Morikawa S, Nakano A, Morikawa K. Torii I, et al. J Cell Physiol. 2003 Oct;197(1):42-52. doi: 10.1002/jcp.10326. J Cell Physiol. 2003. PMID: 12942539 - Properties of growth hormone receptors in relation to the adipose conversion of 3T3 cells.
Nixon T, Green H. Nixon T, et al. J Cell Physiol. 1983 Jun;115(3):291-6. doi: 10.1002/jcp.1041150312. J Cell Physiol. 1983. PMID: 6304120 - Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, Koeffler HP. Kubota T, et al. Cancer Res. 1998 Aug 1;58(15):3344-52. Cancer Res. 1998. PMID: 9699665
Cited by
- Adipose tissue-selective ablation of ADAM10 results in divergent metabolic phenotypes following long-term dietary manipulation.
Marino L, Ni B, Farrar JS, Lownik JC, Pearce JV, Martin RK, Celi FS. Marino L, et al. Adipocyte. 2024 Dec;13(1):2339418. doi: 10.1080/21623945.2024.2339418. Epub 2024 May 5. Adipocyte. 2024. PMID: 38706095 Free PMC article. - New role for the anandamide metabolite prostaglandin F2α ethanolamide: Rolling preadipocyte proliferation.
Boubertakh B, Courtemanche O, Marsolais D, Di Marzo V, Silvestri C. Boubertakh B, et al. J Lipid Res. 2023 Nov;64(11):100444. doi: 10.1016/j.jlr.2023.100444. Epub 2023 Sep 18. J Lipid Res. 2023. PMID: 37730163 Free PMC article. - A simplified and defined serum-free medium for cultivating fat across species.
Mitić R, Cantoni F, Börlin CS, Post MJ, Jackisch L. Mitić R, et al. iScience. 2022 Dec 17;26(1):105822. doi: 10.1016/j.isci.2022.105822. eCollection 2023 Jan 20. iScience. 2022. PMID: 36636339 Free PMC article. - Transcriptional networks controlling stromal cell differentiation.
Rauch A, Mandrup S. Rauch A, et al. Nat Rev Mol Cell Biol. 2021 Jul;22(7):465-482. doi: 10.1038/s41580-021-00357-7. Epub 2021 Apr 9. Nat Rev Mol Cell Biol. 2021. PMID: 33837369 Review. - MD-1, a poly herbal formulation indicated in diabetes mellitus ameliorates glucose uptake and inhibits adipogenesis - an in vitro study.
Telapolu S, Kalachavedu M, Punnoose AM, Bilikere D. Telapolu S, et al. BMC Complement Altern Med. 2018 Apr 2;18(1):113. doi: 10.1186/s12906-018-2177-x. BMC Complement Altern Med. 2018. PMID: 29606113 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources